APA (7th ed.) Citation

Shi, W., Tang, H., Tong, L., Song, P., Huang, Y., Wan, Z., . . . Xie, H. (2025). Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma. Cancer Cell International, 25(1), 1. https://doi.org/10.1186/s12935-025-03902-y

Chicago Style (17th ed.) Citation

Shi, Wenhao, et al. "Dual Targeting of VEGFR2 and CSF1R with SYHA1813 Confers Novel Strategy for Treating Both BRAF Wild-type and Mutant Melanoma." Cancer Cell International 25, no. 1 (2025): 1. https://doi.org/10.1186/s12935-025-03902-y.

MLA (9th ed.) Citation

Shi, Wenhao, et al. "Dual Targeting of VEGFR2 and CSF1R with SYHA1813 Confers Novel Strategy for Treating Both BRAF Wild-type and Mutant Melanoma." Cancer Cell International, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12935-025-03902-y.